The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction

Moshe Phillip, Richard M. Bergenstal, Kelly L. Close, Thomas Danne, Satish K. Garg, Lutz Heinemann, Irl B. Hirsch, Boris Kovatchev, Lori M. Laffel, Viswanathan Mohan,

Diabetes Technology & Therapeutics · 2020 · 143 citations · 45 references

DOIFull text

Open access

Concepts

TL;DR

The rising prevalence of diabetes and a global shortage of health‑care professionals drive the need for new care delivery models, and digital/virtual diabetes clinics offer a promising solution, though several challenges remain unresolved. This article summarizes the panel’s discussion on opportunities, obstacles, and requirements for making digital diabetes technologies a standard of care. In February 2020, an international panel of clinicians, researchers, patient advocates, and industry experts convened at the Advanced Technologies & Treatments for Diabetes conference to review current technologies, identify deficits, and outline key issues. Since that meeting, the COVID‑19 pandemic has highlighted the importance of telehealth and digital diabetes technologies.

Abstract

The increasing prevalence of diabetes, combined with a growing global shortage of health care professionals (HCP), necessitates the need to develop new approaches to diabetes care delivery to expand access to care, lessen the burden on people with diabetes, improve efficiencies, and reduce the unsustainable financial liability on health systems and payers. Use of digital diabetes technologies and telehealth protocols within a digital/virtual diabetes clinic has the potential to address these challenges. However, several issues must be resolved to move forward. In February 2020, organizers of the Advanced Technologies & Treatments for Diabetes Annual Conference convened an international panel of HCP, researchers, patient advocates, and industry representatives to review the status of digital diabetes technologies, characterize deficits in current technologies, and identify issues for consideration. Since that meeting, the importance of using telehealth and digital diabetes technologies has been demonstrated amid the global coronavirus disease (COVID-19) pandemic. This article summarizes the panel's discussion of the opportunities, obstacles, and requisites for advancing the use of these technologies as a standard of care for the management of diabetes.

References

45